UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel

Annals of oncology, 2008-03, Vol.19 (3), p.420-432

2008

Volltextzugriff (PDF)

Bone-targeted agents and skeletal-related events in breast cancer patients with bone metastases: the state of the art

Current oncology (Toronto), 2012-10, Vol.19 (5), p.259-268

2012

Volltextzugriff (PDF)

A Teaching Model for Aromatase Inhibitors After Tamoxifen

Journal of cancer education, 2010-12, Vol.25 (4), p.493-496

2010

Volltextzugriff (PDF)

Five Versus More Than Five Years of Tamoxifen Therapy for Breast Cancer Patients With Negative Lymph Nodes and Estrogen Receptor-Positive Tumors

JNCI : Journal of the National Cancer Institute, 1996-11, Vol.88 (21), p.1529-1542

1996

Volltextzugriff (PDF)

High-dose mitoxantrone–vinblastine–cyclophosphamide and autologous stem cell transplantation for stage III breast cancer: final results of a prospective multicentre study

Annals of oncology, 2005-09, Vol.16 (9), p.1463-1468

2005

Volltextzugriff (PDF)

A high incidence of vertebral fracture in women with breast cancer

British journal of cancer, 1999-03, Vol.79 (7-8), p.1179-1181

1999

Volltextzugriff (PDF)

Should bisphosphonates be standard therapy for bone pain?

Supportive care in cancer, 1997-05, Vol.5 (3), p.200-204

PATERSON, A. H. G

1997

Volltextzugriff (PDF)

Current status of adjuvant bisphosphonates in operable breast cancer

Breast cancer online, 2008-04, Vol.11 (4), p.e7-e7, Article e7

Paterson, A. H. G.

2008

Volltextzugriff (PDF)

Current use of Bisphosphonates in oncology

Journal of clinical oncology, 1998-12, Vol.16 (12), p.3890-3899

1998

Volltextzugriff (PDF)

Increased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer

Journal of clinical oncology, 1996-10, Vol.14 (10), p.2731-2737

1996

Volltextzugriff (PDF)

Oral clodronate and reduction in loss of bone mineral density in women with operable primary breast cancer

JNCI : Journal of the National Cancer Institute, 1998-05, Vol.90 (9), p.704-708

1998

Volltextzugriff (PDF)

Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer

Journal of clinical oncology, 1993-01, Vol.11 (1), p.59-65

1993

Volltextzugriff (PDF)

Clodronate decreases the frequency of skeletal metastases in women with breast cancer

Bone (New York, N.Y.), 1996-12, Vol.19 (6), p.663-667

1996

Volltextzugriff (PDF)

The potential role of bisphosphonates as adjuvant therapy in the prevention of bone metastases

Cancer, 2000-06, Vol.88 (S12), p.3038-3046

Paterson, Alexander H. G.

2000

Volltextzugriff (PDF)

A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors

The New England journal of medicine, 1989-02, Vol.320 (8), p.479-484

1989

Volltextzugriff (PDF)

Oral clodronate maintains bone mass in women with primary breast cancer

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.535-535

2005

Volltextzugriff (PDF)

Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer

Cancer research (Chicago, Ill.), 1991-01, Vol.51 (2), p.556-567

1991

Volltextzugriff (PDF)

A randomized, controlled trial of intravenous clodronate in patients with metastatic bone disease and pain

Journal of pain and symptom management, 1997-06, Vol.13 (6), p.319-326

1997

Volltextzugriff (PDF)

Randomized trial of cyclophosphamide, methotrexate, and fluorouracil chemotherapy added to tamoxifen as adjuvant therapy in postmenopausal women with node-positive estrogen and/or progesterone receptor-positive breast cancer : A report of the National Cancer Institute of Canada Clinical Trials Group

Journal of clinical oncology, 1997-06, Vol.15 (6), p.2302-2311

1997

Volltextzugriff (PDF)

Bisphosphonates: Biological Response Modifiers in Breast Cancer

Clinical breast cancer, 2002-08, Vol.3 (3), p.206-216

Paterson, A.H.G.

2002

Volltextzugriff (PDF)

A randomized crossover trial of tamoxifen versus ovarian ablation for metastatic breast cancer in premenopausal women : A report of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) trial MA.1

Breast cancer research and treatment, 1997-07, Vol.44 (3), p.211-215

1997

Volltextzugriff (PDF)

The Emerging Role of Bisphosphonates in the Prevention of Bone Metastases

Trends in Endocrinology & Metabolism, 1999-01, Vol.10 (1), p.24-29

Paterson, Alexander H.G.

1999

Volltextzugriff (PDF)

Narcotics plus methylphenidate (Ritalin) for advanced cancer pain

The American journal of nursing, 1988-11, Vol.88 (11), p.1555-1556

1988

Volltextzugriff (PDF)

Benefit of aggressive multimodality therapy with autologous stem cell support for intra-abdominal desmoplastic small round cell tumor

Bone marrow transplantation (Basingstoke), 1998-05, Vol.21 (9), p.961-963

1998

Volltextzugriff (PDF)

A double-blind, crossover trial of intravenous clodronate in metastatic bone pain

Journal of pain and symptom management, 1992, Vol.7 (1), p.4-11

1992

Volltextzugriff (PDF)

1 – 25 von 1.512

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.371)
Mit Volltextzugriff
(1.222)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(928)
Life Sciences & Biomedicine
(702)
Humans
(501)
Female
(325)
Male
(311)
Biological And Medical Sciences
(304)
Medical Sciences
(215)
Animals
(199)
Adult
(175)
Middle Aged
(175)
Physical Sciences
(165)
Aged
(126)
Fundamental And Applied Biological Sciences. Psychology
(102)
Physics
(101)
Oncology
(81)
Genetics & Heredity
(69)
Social Sciences
(69)
Psychology
(68)
Rats
(66)
Technology
(66)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(707)
EZB Electronic Journals Library
(632)
Journals@Ovid Complete
(588)
Ingenta
(524)
Single Journals
(413)
Elsevier ScienceDirect Journals
(243)
Wiley Online Library Journals
(211)
IngentaConnect Journals
(201)
Wiley Online Library
(159)
SpringerLink_现刊
(152)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(140)
JSTOR
(127)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(118)
Oxford journals
(110)
Nature_系列刊
(88)
EBSCOhost Business Source Ultimate
(65)
Taylor & Francis Current Content Access
(64)
BMJ Publishing
(62)
Nexis Uni
(61)
Taylor & Francis Online
(58)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel

Bone-targeted agents and skeletal-related events in breast cancer patients with bone metastases: the state of the art

A Teaching Model for Aromatase Inhibitors After Tamoxifen

Five Versus More Than Five Years of Tamoxifen Therapy for Breast Cancer Patients With Negative Lymph Nodes and Estrogen Receptor-Positive Tumors

High-dose mitoxantrone–vinblastine–cyclophosphamide and autologous stem cell transplantation for stage III breast cancer: final results of a prospective multicentre study

A high incidence of vertebral fracture in women with breast cancer

Should bisphosphonates be standard therapy for bone pain?

Current status of adjuvant bisphosphonates in operable breast cancer

Current use of Bisphosphonates in oncology

Increased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer

Oral clodronate and reduction in loss of bone mineral density in women with operable primary breast cancer

Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer

Clodronate decreases the frequency of skeletal metastases in women with breast cancer

The potential role of bisphosphonates as adjuvant therapy in the prevention of bone metastases

A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors

Oral clodronate maintains bone mass in women with primary breast cancer

Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer

A randomized, controlled trial of intravenous clodronate in patients with metastatic bone disease and pain

Randomized trial of cyclophosphamide, methotrexate, and fluorouracil chemotherapy added to tamoxifen as adjuvant therapy in postmenopausal women with node-positive estrogen and/or progesterone receptor-positive breast cancer : A report of the National Cancer Institute of Canada Clinical Trials Group

Bisphosphonates: Biological Response Modifiers in Breast Cancer

A randomized crossover trial of tamoxifen versus ovarian ablation for metastatic breast cancer in premenopausal women : A report of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) trial MA.1

The Emerging Role of Bisphosphonates in the Prevention of Bone Metastases

Narcotics plus methylphenidate (Ritalin) for advanced cancer pain

Benefit of aggressive multimodality therapy with autologous stem cell support for intra-abdominal desmoplastic small round cell tumor

A double-blind, crossover trial of intravenous clodronate in metastatic bone pain

Suchergebnisse filtern